Originally aired on Tuesday, July 23rd, 2019 • Hosted by the Infectious Disease Community of Practice (IDCOP)
"A prospective multicenter observational study of cell‐mediated immunity as a predictor for cytomegalovirus infection in kidney transplant recipients"
(Am J Transplant. 2019 Feb 15. doi: 10.1111/ajt.15315.)
In this article:
Through a large, multicenter trial of kidney transplant recipients, the authors of the article show that an assessment of CMV‐specific immunity using a novel ELISPOT assay is able to predict protection from CMV infection.
Camille Kotton, MD, FAST, FIDSA • Massachusetts General Hospital, Boston, MA
Raymund Razonable, MD • Mayo Clinic College of Medicine & Science, Rochester, MN